Frost & Sullivan Announces Analyst Briefing on Indian Oncology Market

Printer-friendly versionPDF version

The Healthcare practice at Frost & Sullivan, a Growth Partnership Company is pleased to host an Analyst Briefing on the Indian Oncology Market. The presentation will be held on Tuesday, March 30 at 3:00 pm Indian Standard Time.

Mumbai, India - The latest research of Frost & Sullivan on 'Overview of Indian oncology market' presents an all-encompassing research of Oncology markets for various cancers: Breast cancer, Lung Cancer, Ovarian cancer, Prostate cancer, Head and Neck cancer, Cervical cancer, Renal cell carcinoma and Pancreatic cancer. The research focuses on pharmaceutical industry spending in various segments of cancer treatment. Cancer is the leading cause of death in India, so the Oncology therapeutic market is growing at a very high speed. The research study of this market represents the competition and strategic analysis of various segments of cancer market.

Oncology market is the most attractive and growing healthy. Most of the MNCs present capture maximum market share, but hardly anybody knows about the market and its dynamics. Most of the players are not sure about where the market is moving and each one is trying to increase its sales as maximum as possible.

Through this briefing, we shall present active reforms and recommendations that could be followed to plan out the strategy in the cancer market. The briefing, besides covering an analysis of the drivers and key constraints that affects growth of Oncology market, shall also cover the diseases including its impact on local and global scenario.

The briefing will benefit the API manufacturers, finished formulation manufacturers, marketers, decision makers, by discussing the market trends and future drivers in Indian context.

According to Frost & Sullivan Program Manager Bibhuti Bhusan Kar "Lack of any authenticated and audited data on the market, absence of any standardized treatment protocol, and increasing demand for newer and newer molecules for treatment has made the marketers to plan very wisely. Knowing the market better would solve the purpose."

To participate in this briefing, or for an interview, please email Anish Charles at anishc[.]frost.com with the following information: your full name, company name, title, telephone number, office email id, address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the Indian Oncology Market in India, then send an email to Anish Charles / Nimisha Iyer, Corporate Communications, at anishc[.]frost.com / niyer[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Contact:

Anish Charles
Corporate Communications – South Asia
P: +91.22.4001 3419
F: +91.22.2832 4713
E: anishc@frost.com

News Source : Frost & Sullivan announces Analyst Briefing on Indian Oncology Market